| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.27e-05 | 1412 | 7 | 5 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 8.30e-04 | 1459 | 7 | 4 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.98e-03 | 1244 | 7 | 3 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.42e-03 | 1271 | 7 | 3 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.50e-02 | 560 | 7 | 2 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.53e-02 | 566 | 7 | 2 | GO:0001216 | |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification, embryo | 1.94e-05 | 24 | 6 | 2 | GO:0008595 | |
| GeneOntologyBiologicalProcess | tripartite regional subdivision | 1.94e-05 | 24 | 6 | 2 | GO:0007351 | |
| GeneOntologyBiologicalProcess | blastoderm segmentation | 4.18e-05 | 35 | 6 | 2 | GO:0007350 | |
| GeneOntologyBiologicalProcess | embryonic axis specification | 9.29e-05 | 52 | 6 | 2 | GO:0000578 | |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification | 1.59e-04 | 68 | 6 | 2 | GO:0009948 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 2.85e-04 | 91 | 6 | 2 | GO:0009880 | |
| GeneOntologyBiologicalProcess | axis specification | 4.40e-04 | 113 | 6 | 2 | GO:0009798 | |
| GeneOntologyBiologicalProcess | segmentation | 5.21e-04 | 123 | 6 | 2 | GO:0035282 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 6.27e-04 | 135 | 6 | 2 | GO:2000177 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.85e-03 | 233 | 6 | 2 | GO:0061351 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 2.08e-03 | 247 | 6 | 2 | GO:0009952 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.36e-03 | 1053 | 6 | 3 | GO:0000122 | |
| GeneOntologyBiologicalProcess | central nervous system development | 3.41e-03 | 1197 | 6 | 3 | GO:0007417 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 3.67e-03 | 330 | 6 | 2 | GO:0040029 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 5.33e-03 | 1399 | 6 | 3 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 5.48e-03 | 1413 | 6 | 3 | GO:1902679 | |
| GeneOntologyBiologicalProcess | regionalization | 7.56e-03 | 478 | 6 | 2 | GO:0003002 | |
| GeneOntologyBiologicalProcess | pattern specification process | 9.10e-03 | 526 | 6 | 2 | GO:0007389 | |
| GeneOntologyCellularComponent | nuclear speck | 8.32e-03 | 431 | 7 | 2 | GO:0016607 | |
| GeneOntologyCellularComponent | chromatin | 9.98e-03 | 1480 | 7 | 3 | GO:0000785 | |
| HumanPheno | Scimitar anomaly | 1.39e-06 | 4 | 3 | 2 | HP:0011626 | |
| HumanPheno | Partial anomalous pulmonary venous return | 1.27e-05 | 11 | 3 | 2 | HP:0010773 | |
| HumanPheno | Accessory spleen | 1.53e-04 | 37 | 3 | 2 | HP:0001747 | |
| HumanPheno | Hypoplastic left heart | 2.70e-04 | 49 | 3 | 2 | HP:0004383 | |
| HumanPheno | Second trimester onset | 2.93e-04 | 51 | 3 | 2 | HP:0034198 | |
| HumanPheno | Congenital malformation of the left heart | 2.93e-04 | 51 | 3 | 2 | HP:0045017 | |
| HumanPheno | Hypoplastic heart | 3.29e-04 | 54 | 3 | 2 | HP:0001961 | |
| HumanPheno | Enlarged kidney | 6.88e-04 | 78 | 3 | 2 | HP:0000105 | |
| HumanPheno | Anomalous pulmonary venous return | 7.79e-04 | 83 | 3 | 2 | HP:0010772 | |
| HumanPheno | Abnormal pulmonary vein morphology | 8.95e-04 | 89 | 3 | 2 | HP:0030968 | |
| HumanPheno | Abnormality of the pulmonary veins | 8.95e-04 | 89 | 3 | 2 | HP:0011718 | |
| HumanPheno | Congenital diaphragmatic hernia | 1.13e-03 | 100 | 3 | 2 | HP:0000776 | |
| HumanPheno | Supernumerary spleens | 1.15e-03 | 101 | 3 | 2 | HP:0009799 | |
| HumanPheno | Atrial septal defect | 1.19e-03 | 541 | 3 | 3 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 1.19e-03 | 541 | 3 | 3 | HP:0001630 | |
| HumanPheno | Abnormal atrial septum morphology | 1.21e-03 | 544 | 3 | 3 | HP:0011994 | |
| HumanPheno | Abnormal aortic arch morphology | 1.34e-03 | 109 | 3 | 2 | HP:0012303 | |
| HumanPheno | Ambiguous genitalia | 1.74e-03 | 124 | 3 | 2 | HP:0000062 | |
| HumanPheno | Abnormal cardiac atrium morphology | 1.77e-03 | 617 | 3 | 3 | HP:0005120 | |
| HumanPheno | Pulmonary hypoplasia | 2.09e-03 | 136 | 3 | 2 | HP:0002089 | |
| HumanPheno | Abnormality of the diaphragm | 2.24e-03 | 141 | 3 | 2 | HP:0000775 | |
| HumanPheno | Abnormal scrotum morphology | 2.30e-03 | 143 | 3 | 2 | HP:0000045 | |
| HumanPheno | Dextrocardia | 2.85e-03 | 159 | 3 | 2 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 2.88e-03 | 160 | 3 | 2 | HP:0004307 | |
| HumanPheno | Aplasia/Hypoplasia of the lungs | 2.88e-03 | 160 | 3 | 2 | HP:0006703 | |
| HumanPheno | Eclabion | 3.33e-03 | 172 | 3 | 2 | HP:0012472 | |
| HumanPheno | Abnormal cardiac septum morphology | 3.68e-03 | 787 | 3 | 3 | HP:0001671 | |
| HumanPheno | Abnormal heart morphology | 3.80e-03 | 184 | 3 | 2 | HP:3000001 | |
| HumanPheno | Tetralogy of Fallot | 3.84e-03 | 185 | 3 | 2 | HP:0001636 | |
| HumanPheno | Fetal onset | 4.39e-03 | 198 | 3 | 2 | HP:0011461 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.52e-05 | 908 | 7 | 4 | 19274049 | |
| Pubmed | 3.58e-05 | 46 | 7 | 2 | 20301533 | ||
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 3.75e-05 | 272 | 7 | 3 | M1938 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 3.83e-05 | 36 | 7 | 2 | MM3660 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 4.18e-05 | 282 | 7 | 3 | MM822 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN | 1.51e-04 | 71 | 7 | 2 | M707 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS | 1.91e-04 | 80 | 7 | 2 | M40273 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS | 2.31e-04 | 88 | 7 | 2 | M40217 | |
| Coexpression | DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS | 3.68e-04 | 111 | 7 | 2 | M40192 | |
| Coexpression | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 7.06e-04 | 154 | 7 | 2 | M19681 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 7.16e-04 | 155 | 7 | 2 | M8944 | |
| Coexpression | CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL | 1.13e-03 | 195 | 7 | 2 | M39303 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8A_DC_DN | 1.17e-03 | 199 | 7 | 2 | M10029 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 1.19e-03 | 200 | 7 | 2 | M10091 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M9627 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Lypd1_(dSPN,_patch)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.57e-05 | 67 | 7 | 2 | 4fb4381133cfc3a2d5b633eea76c4fc4ef051f08 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Lypd1_(dSPN,_patch)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.57e-05 | 67 | 7 | 2 | 45228b2a1e445ecba32820a282088fd0c4bb2929 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.72e-04 | 130 | 7 | 2 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 156 | 7 | 2 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-04 | 164 | 7 | 2 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 166 | 7 | 2 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-04 | 166 | 7 | 2 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-04 | 166 | 7 | 2 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-04 | 167 | 7 | 2 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 167 | 7 | 2 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 167 | 7 | 2 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 167 | 7 | 2 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-04 | 167 | 7 | 2 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 167 | 7 | 2 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.88e-04 | 168 | 7 | 2 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 169 | 7 | 2 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 169 | 7 | 2 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-04 | 171 | 7 | 2 | e780e63510ca47036bc36ca40ecff4098596ee9e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.01e-04 | 172 | 7 | 2 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 173 | 7 | 2 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 173 | 7 | 2 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 173 | 7 | 2 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 173 | 7 | 2 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 173 | 7 | 2 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 173 | 7 | 2 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 173 | 7 | 2 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.08e-04 | 174 | 7 | 2 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.12e-04 | 175 | 7 | 2 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 175 | 7 | 2 | f5451c29c487b998778e50349b3d774d5e20fd28 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 176 | 7 | 2 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 176 | 7 | 2 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-04 | 178 | 7 | 2 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-04 | 178 | 7 | 2 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-04 | 178 | 7 | 2 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.23e-04 | 178 | 7 | 2 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-04 | 178 | 7 | 2 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 179 | 7 | 2 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 179 | 7 | 2 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-04 | 179 | 7 | 2 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.30e-04 | 180 | 7 | 2 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 3.30e-04 | 180 | 7 | 2 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 181 | 7 | 2 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 181 | 7 | 2 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 181 | 7 | 2 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-04 | 181 | 7 | 2 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.37e-04 | 182 | 7 | 2 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 3.37e-04 | 182 | 7 | 2 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 183 | 7 | 2 | 03649492c37f9b274a1caf3e2132ce2915cf1df5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 183 | 7 | 2 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 183 | 7 | 2 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.41e-04 | 183 | 7 | 2 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 184 | 7 | 2 | e0beb016823514eebdbfc13beb0807efb4470f08 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.45e-04 | 184 | 7 | 2 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.45e-04 | 184 | 7 | 2 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.45e-04 | 184 | 7 | 2 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.45e-04 | 184 | 7 | 2 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.48e-04 | 185 | 7 | 2 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-04 | 185 | 7 | 2 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.52e-04 | 186 | 7 | 2 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 186 | 7 | 2 | a66da8453bb78f7e9f5f59452b3c50ae679d83c3 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Early_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 186 | 7 | 2 | ae4b6ecfc1850c0a01a11b9dd9718880f2a24fe0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.56e-04 | 187 | 7 | 2 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.60e-04 | 188 | 7 | 2 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-04 | 188 | 7 | 2 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.60e-04 | 188 | 7 | 2 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-04 | 188 | 7 | 2 | 00c5259bcb83218b7d44f4d585d9b68ef49763ab | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.60e-04 | 188 | 7 | 2 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-04 | 190 | 7 | 2 | f39ce1678fc375eb2a3af781ddb772b0f12c5744 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 3.67e-04 | 190 | 7 | 2 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.67e-04 | 190 | 7 | 2 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 3.67e-04 | 190 | 7 | 2 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-04 | 191 | 7 | 2 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.71e-04 | 191 | 7 | 2 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.71e-04 | 191 | 7 | 2 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-04 | 191 | 7 | 2 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.71e-04 | 191 | 7 | 2 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.75e-04 | 192 | 7 | 2 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-04 | 192 | 7 | 2 | 2f539653a20006bef814e6b4acd1023d6fdad5c6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 193 | 7 | 2 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 193 | 7 | 2 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.83e-04 | 194 | 7 | 2 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | IPF-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 3.83e-04 | 194 | 7 | 2 | d8a26da856a85e3d001d406e992cb18fdd58baef | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-04 | 194 | 7 | 2 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-04 | 194 | 7 | 2 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-04 | 194 | 7 | 2 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-04 | 195 | 7 | 2 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-04 | 195 | 7 | 2 | 8a9d05f7a5397836b7dfb8ae4f7c4896042ac0fe | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 195 | 7 | 2 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-04 | 195 | 7 | 2 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | 429de4119c8b2193c992d36a6af84f806730cbee | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | ee89f6884aea11aefeaabe043db7f80145dcdf7f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | 8c8a73d9d9581b8d9a9babfa93459d12fb9eb3ac | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | e75c36cb042342d69a593fb1ce62fab033889871 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-04 | 196 | 7 | 2 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 7 | 2 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 7 | 2 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 7 | 2 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 7 | 2 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-04 | 198 | 7 | 2 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-04 | 198 | 7 | 2 | 5375a2895cf995f0db4a61861093f01794707901 | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.05e-05 | 193 | 7 | 3 | 4583_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.14e-05 | 196 | 7 | 3 | 4597_UP | |
| Drug | Puromycin dihydrochloride [58-58-2]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.18e-03 | 173 | 7 | 2 | 2448_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.34e-03 | 185 | 7 | 2 | 4327_DN | |
| Drug | Deferoxamine | 1.36e-03 | 186 | 7 | 2 | ctd:D003676 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.36e-03 | 186 | 7 | 2 | 6198_DN | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A | 1.40e-03 | 189 | 7 | 2 | 6170_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.40e-03 | 189 | 7 | 2 | 6717_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.43e-03 | 191 | 7 | 2 | 2499_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; HL60; HT_HG-U133A | 1.44e-03 | 192 | 7 | 2 | 1337_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 4338_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 4067_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 2098_DN | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 1316_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 7379_UP | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 2206_DN | |
| Drug | Methocarbamol [532-03-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 2111_DN | |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 4251_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 5767_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 7377_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 3762_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 1531_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4482_UP | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; HL60; HG-U133A | 1.50e-03 | 196 | 7 | 2 | 1996_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 6684_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 5593_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 1326_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5057_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5276_UP | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 7440_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 7265_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 4295_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; HL60; HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1774_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 3723_DN | |
| Drug | Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 4635_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | 1.54e-03 | 198 | 7 | 2 | 1609_DN | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; HL60; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 2910_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 5729_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 4099_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 4551_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 3509_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; HL60; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 2356_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 5797_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 6935_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 3793_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 3082_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 5785_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 2931_UP | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 3744_DN | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 5740_DN | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; HL60; HG-U133A | 1.55e-03 | 199 | 7 | 2 | 1784_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 4297_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 4561_DN | |
| Disease | respiratory system disease | 3.55e-04 | 145 | 6 | 2 | EFO_0000684 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 1.46e-03 | 295 | 6 | 2 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | QRS duration | 1.48e-03 | 298 | 6 | 2 | EFO_0005055 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPPQPPPPPPPPPPH | 161 | Q5VYV0 | |
| PPPHPPPPPPPPPCG | 111 | P13378 | |
| PPPPEYPPPPPPPPH | 641 | O15047 | |
| PPPAPPPPPPPPPHS | 56 | P19544 | |
| HHPAPPPPPPPPPPP | 691 | Q2VWA4 | |
| PPPPPPGPPPPPTFH | 6 | Q8TF74 | |
| PPAHLPGPPPPPPPP | 181 | Q9Y2G1 | |
| PGPPPPPPPPPHYPV | 186 | Q9Y2G1 |